Influence of the type of salt-forming acids on the antiradiation activity of T1023 analogs – salts of N-isobutanoyl-S-isopropylisothiourea

According to leading experts, the vast arsenal of radioprotective agents available in the world today does not fully meet modern practical needs, both in the field of radiation protection, and in the prevention and treatment of complications of radiotherapy. The purpose of the study was to evaluate the effect of the salt-forming acids type on the radioprotective activity of NOS inhibitor T1023. The chemical part of this study included methods of chemical synthesis, physicochemical and elemental analysis. Pharmacological part – assessment of acute toxicity using V.B. Prozorovsky express method and the study of radioprotective activity using Till and McCulloch method based on the ability of mice hematopoietic cells to form spleen colonies after irradiation. The number of endogenous hematopoietic spleen colonies were assessed on the 8th day after total exposure to gamma-irradiation at a dose of 6 Gy in six independent experiments. As a result of directed chemical synthesis, six new derivatives of T1023 – salts of N-isobutanoyl-S-isopropylisothiourea have been developed, identified and characterized. The results of studying the safety and radioprotective activity of the synthesized compounds showed that changes in the salt-forming acid don’t significantly influence the toxicity: all studied compounds are in the 3rd class of toxicity and hazard. At the same time, it was found that the replacement of the salt-forming acid significantly influenced the severity of the radioprotective effect. For some of these compounds radioprotective efficacy is comparable to or exceeds the efficacy of the initial compound T1023. It is important to note that these new compounds were used in lower, more save doses than T1023. The results suggest promising further development of NOS inhibitors – isothiourea derivatives as radioprotective agents.

1. Grebenyuk AN, Gladkikh VD. Modern condition and prospects for the development of medicines towards prevention and early treatment of radiation damage. Biology bulletin. 2019;46(11): 1540-1555.

2. Rozhdestvensky LM. Challenges of development of radiation countermeasures. Radiatsionnaya biologiya. Radioekologiya = Radiation Biology. Radioecology. 2019;59(2): 117-126. (In Russian).

3. Singh VK, Newman VL, Romaine PL, Wise AY, Seed TM. Radiation countermeasure agents: an update (2011-2014). Expert Opinion on Therapeutic Patents. 2014;24(11): 1229-1255.

4. Singh VK, Seed TM, Olabisi AO. Drug discovery strategies for acute radiation syndrome. Expert Opinion on Drug Discovery. 2019;14(7): 701–715.

5. Rozhdestvensky LM. Actual problems of searching and studying radiation countermeasures. Radiatsionnaya biologiya. Radioekologiya = Radiation Biology. Radioecology. 2013;53(5): 513-520. (In Russian).

6. Gudkov SV, Popova NR, Bruskov VI. Radioprotectors: History, Trends and Prospects. Biofizika = Biophysics. 2015;60(4): 801-811. (In Russian).

7. Filimonova MV, Filimonov AS. Contemporary problems and perspectives of development and implementationof domestic radioprotective drugs. Radiatsionnaya biologiya. Radioekologiya = Radiation Biology. Radioecology. 2019;59(2): 127-131. (In Russian).

8. Víteček J, Lojek A, Valacchi G, Kubala L. Arginine-Based Inhibitors of Nitric Oxide Synthase: Therapeutic Potential and Challenges. Mediators of Inflammation. 2012. 2012: Art.ID: 318087.

9. Filimonova MV, Proskuryakov SI, Shevchenko LI, Shevchuk AS, Lushnikova GA, Makarchuk VM, et al. Radioprotective properties of isothiourea derivatives with NO-inhibitory mechanism of action. Radiatsionnaya biologiya. Radioekologiya = Radiation Biology. Radioecology. 2012;52(6): 593-601. (In Russian).

10. Minhas R, Bansal Y, Bansal G. Inducible nitric oxide synthase inhibitors: A comprehensive update. Medicinal Research Reviews. 2020;40(3): 823-855.

11. Filimonova MV, Shevchenko LI, Trofimova TP, Makarchuk VM, Shevchuk AS, Lushnikova GA. On the mechanism of radioprotective effect of NO-synthase inhibitors. Radiatsionnaya biologiya. Radioekologiya = Radiation Biology. Radioecology. 2014;54(5): 500-506. (In Russian).

12. Filimonova MV, Shevchenko LI, Makarchuk VM, Chesnakova EA, Izmestyeva OS, Korneeva TS, et al. Radioprotective properties of NO-synthase inhibitor T1023: I. Indicators of radioprotective activity and interaction with other radioprotectors. Radiatsionnaya biologiya. Radioekologiya = Radiation Biology. Radioecology. 2015;55(3): 250-259. (In Russian).

13. Mironov AN, Bunyatyan ND, Vasilyev AN, Verstakova OL, Zhuravleva MV. Guidelines of preclinical trials of drugs. Moscow; 2012. Vol. 1. 944 p. (In Russian).

14. Prozorovsky VB, Prozorovskaya MP, Demchenko VM. Express method for determining the average effective dose and its error. Farmakologiya i toksikologiya = Pharmacology and toxicology. 1978;41(4): 497–502. (In Russian).

15. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiation Research. 2012;178(2): AV3-7.

16. Glantz S. Primer of biostatistics. Moscow,1998. 462 p. (In Russian).

17. Berezovskaya IV. Classification of substances with respect to acute toxicity for parenteral administration. Pharmaceutical Chemistry Journal. 2003;37(3): 139-141.